Imatinib Inhibits GH Secretion From Somatotropinomas

Expression of AGR2 in pituitary adenomas and its association with tumor aggressiveness

(2015) MAMATEMIN TOHTI et al.   Oncology Letters

Growth failure in children with chronic myeloid leukemia receiving imatinib is due to disruption of GH/IGF-1 axis

(2013) Karthik R. Narayanan et al.   PEDIATRIC BLOOD & CANCER

Imatinib mesylate causes growth deceleration in pediatric patients with chronic myelogenous leukemia

(2012) Maynika V. Rastogi et al.   PEDIATRIC BLOOD & CANCER

KIT protein expression and mutational status of KIT gene in pituitary adenomas

(2012) Olivera Casar-Borota et al.   VIRCHOWS ARCHIV

EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas

(2011) Hidenori Fukuoka et al.   JOURNAL OF CLINICAL INVESTIGATION

Distinct Impact of Imatinib on Growth at Prepubertal and Pubertal Ages of Children with Chronic Myeloid Leukemia

(2011) Haruko Shima et al.   JOURNAL OF PEDIATRICS

Imatinib has adverse effect on growth in children with chronic myeloid leukemia

(2011) Deepak Bansal et al.   PEDIATRIC BLOOD & CANCER

Anti-VEGF therapy in pituitary carcinoma

(2011) Leon D. Ortiz et al.   Pituitary

VEGF and CD31 Association in Pituitary Adenomas

(2010) Carolina Cristina et al.   ENDOCRINE PATHOLOGY

Acquired growth hormone deficiency in a girl with chronic myelogenous leukemia treated with tyrosine kinase inhibitor therapy

(2010) Susan L. Hobernicht et al.   PEDIATRIC BLOOD & CANCER

Platelet-derived Growth Factor (PDGF) and PDGF Receptor Expression and Function in Folliculostellate Pituitary Cells

(2009) M. Kowarik et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Characterization of C-Kit (CD117) Expression in Human Normal Pituitary Cells and Pituitary Adenomas

(2008) Stefano La Rosa et al.   ENDOCRINE PATHOLOGY

Lack of inhibitory effects of the anti-fibrotic drug imatinib on endothelial cell functionsin vitroandin vivo

(2008) Paulius Venalis et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE